for Precision Medicine
We are dedicated to improving treatment outcomes by providing precision diagnostic and prognostic tools.
Our development pipeline is focused on cancers and neurological disorders.
Our novel 3D technology enables clinicians to develop personalized treatment programs for patients.
Enabling Truly Personalized Medicine
Based on Dr. Sabine Mai’s groundbreaking research, 3D Signatures is the first and only company to understand and quantify normal versus disease state telomere arrangement, turning this into usable, predictable, reliable, and highly valuable information that can improve patient outcomes. This disruptive technology platform is fundamentally different from conventional diagnostic methods and could represent an entirely new class of biomarkers for diseases like cancer and Alzheimer’s.